BDBM412535 US10399972, Example 26::[3,9-difluoro-8-(3-oxa-8- azabicyclo[3.2.1]oct-8-yl)-5,11- dihydro-6H-pyrido[2,3- b][1,5]benzodiazepin-6-yl][trans- 4-(propan-2- yloxy)cyclohexyl]methanone

SMILES CC(C)O[C@H]1CC[C@@H](CC1)C(=O)N1Cc2cc(F)cnc2Nc2cc(F)c(cc12)N1C2CCC1COC2

InChI Key InChIKey=VTSVVHIHYFKVQE-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 412535   

TargetIsocitrate dehydrogenase [NADP] cytoplasmic [R132H](Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM412535(US10399972, Example 26 | [3,9-difluoro-8-(3-oxa-8-...)
Affinity DataIC50: 13.8nMAssay Description:Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series. 125 nL of each dilution or DMSO alone is disp...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
US Patent